Aberrations in ORC6 expression or functionality have been associated with various cancer types, contributing to increased cell proliferation and potentially influencing poor prognosis in certain malignancies such as breast, lung, colorectal, and hepatocellular carcinomas [22–26]. Here, ORC6 is linked to cancer.